Human Interleukin-6 ELISA

Elevated circulating IL-6 levels are associated with an increased risk of major adverse cardiovascular events, including myocardial infarction, stroke, heart failure, and cardiovascular mortality. In clinical research, IL-6 is widely used to assess residual inflammatory risk in patients with established cardiovascular disease and to evaluate the effectiveness of anti-inflammatory therapies. Increased IL-6 concentrations have also been linked to worse outcomes in acute coronary syndromes and chronic heart failure, where they may provide prognostic information beyond traditional cardiovascular risk factors.

References on the product 20+